Serum beta-2-microglobulin binding activity in monoclonal gammopathy: Correlative study and clinical significance
- 1 August 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (8) , 1075-1080
- https://doi.org/10.1016/0277-5379(83)90030-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical statusEuropean Journal of Cancer and Clinical Oncology, 1982
- Prevalence of anti-beta-2 microglobulin autoantibodies in sera of rheumatoid arthritis patients with extra-articular manifestations.Annals of the Rheumatic Diseases, 1981
- Suppression of polyclonal immunoglobulins in multiple myeloma: Relationship to the staging and other manifestations at diagnosisClinical Immunology and Immunopathology, 1980
- Turnover in humans of β2‐microglobulin: the constant chain of HLA‐antigensEuropean Journal of Clinical Investigation, 1980
- REAPPRAISAL OF PLATEAU PHASE IN MYELOMAThe Lancet, 1980
- Serum β2-Microglobulin, Serum Creatinine and Bone Marrow Plasma Cells in Benign and Malignant Monoclonal GammopathyActa Haematologica, 1980
- β2-MICROGLOBULIN, A TUMOUR MARKER OF LYMPHOPROLIFERATIVE DISORDERSThe Lancet, 1978
- β2-Microglobulin levels in cancerous and other disease statesClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Effects of Anti-β2 microglobulin antibodies on human lymphocytesCellular Immunology, 1975
- Interpretation of Serum Calcium in Patients with Abnormal Serum ProteinsBMJ, 1973